Global /South Korea /Healthcare /Medical Devices /450950

ASTERASYS Co.,Ltd

450950

• KRX: 450950 • Delayed

11,470KRW -0.1%

7.48 USD

As of 5 June 2026, ASTERASYS Co.,Ltd has a market cap of $280.77M USD, ranking #18983 globally and #636 in South Korea. It ranks #1712 in the Healthcare sector, and #353 in the Medical Devices industry.

Global Rank

18983

Country Rank

636

Sector Rank

1712

Industry Rank

353

Key Stats

Market Cap

$280.77MUSD

431.59B KRW

Enterprise Value

$266.05MUSD

407.81B KRW

Revenue (TTM)

$24.68MUSD

37.94B KRW

EBITDA (TTM)

$7.95MUSD

12.19B KRW

Net Income (TTM)

$5.99MUSD

9.21B KRW

EBITDA Margin

32%

Profit Margin

24%

PE Ratio

46.6

Forward PE

21.8

PS Ratio

11.4

PB Ratio

9.2

EV/EBITDA

33.5

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Medical Devices

CEO

EunTaek Seo open_in_new

Employees

Founded

2015

Website

asterasys.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.1%	-3.4%	2.1%	-12%	-28%	-7.2%	25%	4.1%	4.1%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	450950 주식회사 아스테라시스 ISIN: KR7450950001 Shares Out.: Shares Outstanding: 37.628M¹ Shares Float: 19.901M² TV: TradingView: KRX: 450950 SA: Stock Analysis: KRX: 450950 YF: Yahoo Finance: 450950.KS GF: Google Finance: KRX: 450950 BA: Barron's: 450950 MS: Morningstar: XKRX: 450950	11,470 KRW	TV: TradingView: KRX: 450950 SA: Stock Analysis: KRX: 450950 YF: Yahoo Finance: 450950.KS GF: Google Finance: KRX: 450950 BA: Barron's: 450950 MS: Morningstar: XKRX: 450950

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About ASTERASYS Co.,Ltd

ASTERASYS Co.,Ltd manufactures and sells medical equipment for hospitals and skin care devices for beauty care clinics and salons in South Korea, Europe, Asia, the Middle East, Africa, North America, South America, Australia, and New Zealand. The company offers Coolfase, a monopolar RF device with direct cooling in tip; Q-facial, a skin management equipment; Liftera for facial skin lifting; Liftera2, a dual-type HIFU technology that enables combination treatments using Line and Pen-type applicators; and Futera Dots for fractional skin resurfacing. It serves healthcare, aesthetics, distribution, and IoT sectors. The company was formerly known as DAIHAN Biomedical Co., Ltd. and changed its name to ASTERASYS Co.,Ltd in January 2018. The company was founded in 2015 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Medical Devices (South Korea)

Name	Market Cap (USD) diff.	PE	Country
CLASSYS Inc. KRX: 214150	$2.44B 3.75T KRW 769%	28.7	South Korea
SEERS Co., Ltd. KRX: 458870	$1.21B 1.86T KRW 332%	114.8	South Korea
Livsmed Inc. KRX: 491000	$1.18B 1.81T KRW 319%	-	South Korea
L&C BIO Co.,LTD KRX: 290650	$1.13B 1.74T KRW 302%	-	South Korea
Seegene, Inc. KRX: 096530	$751.49M 1.16T KRW 168%	23.9	South Korea
i3system Inc. KRX: 214430	$526.7M 809.64B KRW 88%	83.3	South Korea

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 62K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 57K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 57K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 45K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 43K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 36K%	22.2	Ireland

chevron_leftBack